Vol 8, No 3 (June 29, 2019): Chinese Clinical Oncology (Challenges and Insights of Early Oncology Drug Development in the Asia-Pacific Region)

Preface on Challenges and Insights of Early Oncology Drug Development in the Asia- Pacific Region1

Trends in phase 1 oncology drug development in East-Asia and Australia
Brigette B. Y. Ma

Disclosure:

1. The series “Challenges and Insights of Early Oncology Drug Development in the Asia- Pacific Region” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Brigette B. Y. Ma served as the unpaid Guest Editor for the series.